GAPDH and pancreatic neoplasm: A recent report showed that PRMT3-mediated methylation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) at R248 enhances its catalytic activity, thus increasing glycolysis in pancreatic cancer cells [23].